To determine whether recommendations of infectious diseases specialists affect outcome for patients, we evaluated 244 hospitalized patients with Staphylococcus aureus bacteremia. We offered our management recommendations to each patient's physicians and then assessed the clinical outcome for both patients for whom our consultative advice was followed and those for whom our advice was not heeded. All patients were followed up for 12 weeks after their first positive blood culture. Our management advice was followed for 112 patients (45.9%) and partially or completely ignored for 132 patients (54.1%). Patients for whom our recommendations were followed were more likely to be cured of their S. aureus infection and less likely to relapse (P õ .01), despite having significantly more metastatic infections (P õ .01) at the outset of therapy, than were those for whom our recommendations were not followed. Failure to follow recommendations to remove an infected intravascular device was the most important risk for treatment failure. After controlling for other factors, logistic regression analysis revealed that patients whose intravascular device was not removed were 6.5 times more likely to relapse or die of their infection than were those whose device was removed. Our findings suggest that patient-specific management advice by infectious diseases consultants can improve the clinical outcome for patients with S. aureus bacteremia.
Consultation or management advice from subspecialists has
at Duke University Medical Center (Durham, NC) for whom one or more blood cultures were positive for S. aureus and for been shown to improve clinical outcome for patients sustaining an acute myocardial infarction [1] and patients with AIDS [2] .
whom there was clinical evidence of infection. The clinical charts of these patients were then reviewed within 36 hours of However, the impact of consultation by infectious diseases specialists on the clinical outcome for hospitalized patients has the detection of bacteremia. Patients were excluded from the study for the following reasons: age of younger than 18 years, been incompletely studied [3 -6] .
The objective of the following study was to determine polymicrobic infection, neutropenia (WBC count of õ1.0 1 10 9 /L), death before blood cultures were found to be positive, whether recommendations of infectious diseases specialists affect the clinical outcome for hospitalized patients with Staphyoutpatient status, or enrollment in a simultaneous investigation randomizing patients with indwelling catheter -related bacterlococcus aureus bacteremia. During a 25-month period, we identified all hospitalized patients with S. aureus bacteremia, emia to removal or nonremoval of the catheter. To maintain the statistical assumption of independence of values, only the offered our management recommendations to each patient's physicians, and then assessed the clinical outcome for patients initial episode of bacteremia for each patient was included in the study. for whom our consultative advice was and was not followed.
Methods

Clinical Features
Subjects and Setting
Each patient was initially evaluated by a member of the infectious diseases team for signs suggestive of infective endoBetween September 1994 and October 1996, we received carditis (IE) and for clinical evidence of a source of their bacterdaily reports from the microbiology laboratory on all patients emia. IE was defined according to the Duke criteria [7] . Staphylococcal tissue infection was considered the source of bacteremia if clinical signs of a known or suspected soft-tissue attributable to S. aureus bacteremia and the initiation of effecdations were discussed, and an official consultation was offered. The decision to follow our treatment recommendations tive antibiotic therapy.
S. aureus bacteremia was considered to be nosocomial if a (either with or without consultation) was made by each patient's primary physicians. Regardless of the outcome of this blood culture was positive after ú72 hours of hospitalization and clinical signs of S. aureus bacteremia were absent at the decision, the clinical course of each study patient was assessed during the hospital stay by periodic monitoring of the clinical time of admission. S. aureus bacteremia was considered to be community-acquired if a blood culture was positive within 72 chart.
Reasons for failure to follow the recommendations of the hours of admission and/or signs and symptoms consistent with S. aureus bacteremia were present before admission. S. aureus infectious diseases team were categorized as follows: failure to perform TEE, failure to remove an infected intravascular bacteremia was considered to be nursing home -acquired if a blood culture was positive within 72 hours of admission from device, inappropriate vancomycin therapy, treatment for longer than the recommended duration of therapy, and failure to obtain a patient who was transferred from an extended-care facility because of clinical signs of active infection.
blood for surveillance cultures.
Treatment Recommendations
Before the study was initiated, a consensus statement on
Patients were classified as having received vancomycin or b-lactam (nafcillin or cefazolin) therapy if one of these agents the management of S. aureus bacteremia was created by the investigators (table 1) . The following recommendations were was prescribed for the entire treatment period or if therapy was converted to one of these agents within 2 days of initiating made for all patients with S. aureus bacteremia: all removable foci of infection such as catheters should be removed; blood another antibiotic type [10] . Vancomycin (loading dose, 15 -20 mg/kg of body weight) was dosed according to measured for surveillance cultures should be obtained on days 2 -4 of antibiotic therapy; transesophageal echocardiography (TEE) serum drug levels to maintain therapeutic levels, nafcillin was dosed at 2 g intravenously every 4 -6 hours, and cefazolin should be performed on days 5 -7 of antibiotic therapy, or sooner if clinically indicated; and wherever possible, b-lactam was dosed at 1 -2 g intravenously every 8 hours. Vancomycin therapy was categorized as appropriate if the patient was allerantibiotic therapy should be used. Further recommendations were made on the basis of a schema outlined in table 1 [9] . gic to penicillin or had bacteremia due to methicillin-resistant S. aureus (MRSA). Combination therapy with gentamicin A treating physician for each bacteremic patient was contacted by one of the investigators, our management recommen-(3 mg/[kgrd] or an equivalent dosage for patients with renal insufficiency) was administered at the discretion of each pawith the outcome for patients whose infected intravascular device was removed or patients who never had a device. The tient's primary physician. The duration of antibiotic therapy was defined as the length of time the patient received intraveoutcome for patients in whom vancomycin was used inappropriately was compared with the outcome for patients in whom nous antibiotics effective against that patient's S. aureus isolate. We defined abbreviated therapy as antibiotic therapy lasting vancomycin was used appropriately or not used. Kaplan-Meier estimates were used to describe the survival for 7 days, short-course therapy as antibiotic therapy lasting 2 weeks, and long-course therapy as antibiotic therapy lasting distribution for time to defervescence. The logrank statistic was used to test the difference in time to defervescence between §4 weeks. patients whose physicians did and did not follow recommendations. Relationships were considered significant when the two-
Patient Outcome
sided P value was õ.05. Logistic regression was used to evaluate the association between the reason for noncompliance with Follow-up of all living patients was attempted. Twelve weeks after the date of the first blood culture, one of the investithe specialist recommendations and the outcome of death or relapse. Several potential confounding variables were also evalgators (V.G.F.) made telephone contact with the patient, a family member, or the patient's primary care physician and uated for their effect on the group-outcome relationship. inquired about the patient's current condition. In the event of a second hospitalization within 12 weeks of the first hospitalizaResults tion, all pertinent medical records were reviewed. Four primary end points were defined: cure, resolution of clinical signs of One or more cultures of blood specimens from a total of 393 adult inpatients at Duke University Medical Center were infection during therapy and no evidence of recurrent staphylococcal infection at the time of follow-up 12 weeks later; relapse, positive for S. aureus during the study period (figure 1). One hundred forty-eight patients (37.7%) were excluded from the clinical resolution of signs and symptoms of infection during therapy but recurrent S. aureus infection (as confirmed by cultures) within the 12 weeks of follow-up; death due to S. aureus bacteremia, clinical or microbiological evidence of infection at the time of death without an alternate explanation; and death due to underlying disease, no evidence of infection at the time of death due to a defined underlying disease.
Pulsed-Field Gel Electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed on both isolates from patients with a second episode of S. aureus bacteremia to confirm genetic similarity, as described by Kong et al. [11] . Briefly, single isolates grown overnight at 37ЊC on broth medium were embedded into small agarose plugs, digested with lysostaphin and lysozyme, and deproteinized with use of a reagent kit (GenePath I, Bio-Rad, Hercules, CA). Restriction enzymes digested with SmaI underwent electrophoresis on 1% agarose gels and were stained with ethidium bromide; results were interpreted according to previously reported guidelines [12] .
Statistical Analysis
Descriptive statistics for continuous variables were summarized in terms of medians and interquartile ranges. Categorical variables were reported in terms of the number and percent of the consultative advice was followed and the group for which Infectious diseases specialist recommendations were followed by the it was not followed were made with Wilcoxon rank-sum tests physicians of 112 patients (45.9%) and were not followed by the for continuous variables and with Fisher's exact tests for catephysicians of 132 patients (54.1%). One hundred forty-eight patients gorical variables. The outcome for patients whose physicians were excluded from entry into the study. Reasons for study exclusion are given at the bottom of the figure. failed to remove an infected intravascular device was compared study because of reasons noted above, leaving 245 patients groups (P Å .02); and patients for whom recommendations were followed were less likely to be hemodialysis-dependent (62.3%) eligible for the study. Follow-up was performed for 244 patients (99.6%). Our management and therapeutic advice than were those for whom recommendations were not followed (12.5% vs. 28.0%, respectively; P õ .01). was followed by the physicians of 112 patients (45.9%). Consultation was declined and our verbal advice was completely or partially ignored by the physicians of the remaining 132 patients (54.1%).
Outcome
Patient demographics and clinical characteristics are presented in tables 2 and 3. Patients for whom our recommendaFollow-up information was obtained 12 weeks after the onset of S. aureus bacteremia for ú99% of study patients. Patients tions were and were not followed had similar demographic characteristics and frequencies of most comorbidities; they also whose physicians followed the recommendations of infectious diseases specialists were more likely to be cured of their had similar WBC counts (12, ], respectively; P Å NS). The two groups were cared for by a similar distribution of physician specialties, P õ .01) than were patients whose physicians did not follow recommendations of infectious diseases specialists (table 4) . with 24% -27% of patients from a surgical service and 73% -76% of patients from a medical or obstetrical service.
Rates of death due to S. aureus and death due to comorbid conditions were not significantly different among the two Clinical characteristics of the patients whose physicians followed our recommendations differed from those of the patients groups.
Thirty-one patients relapsed within the 12-week follow-up whose physicians did not follow our recommendations in four aspects: the incidence of metastatic infections at the onset of period. Recurrent S. aureus bacteremia was found in 24 patients. Because some episodes of recurrent S. aureus bacteremia therapy was higher among patients for whom recommendations were followed than among those for whom recommendations may have represented reinfection rather than a true relapse of inadequately treated infection, we performed PFGE on all were not followed (42.9% vs. 19.7%, respectively; P õ .01); the median duration of symptoms was longer for patients for available isolates. Isolates from the initial and recurrent episodes of S. aureus bacteremia in 20 (83.3%) of 24 patients whom recommendations were followed than for those for whom recommendations were not followed (3.0 days vs. 2.0 were available for PFGE. Isolates from the recurrent episode of bacteremia in 18 (90%) of these 20 patients were identical days, respectively; P Å .01); rates of hospital and communityacquired bacteremia were significantly different among the two to isolates from the initial episode. NOTE. IE Å infective endocarditis; NS Å not significant at an a of .05 (two-sided). * Acquired by the direct extension of infection.
Our recommendations were followed for seven of the 31 (1), pneumonia (1), and site of injection drug use (1). Three of these 24 patients developed definite IE, and two died of patients with recurrent staphylococcal infection. All seven of these patients originally had a deep-tissue infection (mediastinrecurrent staphylococcemia. Eighteen patients (7.4%) died due to S. aureus infection. itis, 2 patients; psoas abscess, 1; surgical wound infection, 1; septic arthritis, 1; and IE, 2). None of these seven patients died Our recommendations were followed by the physicians of nine of these patients. Six of these nine patients had definite IE. of recurrent staphylococcal infection. Our recommendations were not followed by the physicians of 24 of the 31 patients
The other three patients died of staphylococcal sepsis associated with a deep-tissue infection. Our recommendations were with recurrent bacteremia. The initial site of staphylococcal infection in these 24 patients included the following: intravasnot followed by the physicians of the nine remaining patients who died of staphylococcal infection. Four of these nine pacular devices (14 patients), mediastinitis (4), other surgical wounds (2), entry site of chest catheter (1), diabetic foot ulcer tients died of staphylococcal sepsis associated with a removable The median duration of antibiotic therapy was similar for patients whose physicians followed and did not follow our ics when possible, and failure to perform TEE). After controlrecommendations (21.0 days [interquartile range, 13.0 -36.0 ling for the other variables in the model, patients whose days] vs. 21.0 days [interquartile range, 14.0 -28.0 days], reintravascular device was not removed were 6.5 times more spectively; P Å NS). Sixty-two patients (56.4%) whose physilikely to relapse or die of their infection than were those whose cians followed our recommendations received b-lactam therdevice was removed (OR, 6.5; 95% CI, 2.1 -20.2; P õ .01). apy, while 48 patients (43.6%) whose physicians did not follow Overall, 13 (56.5%) of the 23 patients whose foreign body our recommendations received b-lactam therapy.
was not removed relapsed or died due to S. aureus infection One of the 244 patients died before receiving treatment with compared with 36 (16.3%) of the 221 patients whose infected antistaphylococcal antibiotics. Of the 110 patients treated with foreign body was removed or who did not have a device b-lactam antibiotics, 92 (83.6%) were cured, 4 (3.6%) relapsed (P õ .01). with staphylococcal infection, 6 (5.5%) died due to S. aureus Failure to perform TEE did not increase the risk of relapse infection, and 8 (7.3%) died of comorbidities. Of the 133 paor death due to infection (OR, 1.4; 95% CI, 0.7 -2.9; tients treated with vancomycin, 82 (61.7%) were cured, 27 P Å NS). Because other aspects of our recommendations were (20.3%) relapsed, 12 (9.0%) died of their S. aureus infection, not followed in the management of most patients who received and 12 (9.0%) died of comorbidities. Vancomycin therapy was inappropriate vancomycin therapy, we were unable to detect appropriately given to 96 patients. Eighteen of these patients any independent impact of this potential variable (OR, 1.4; were allergic to penicillin, and 78 patients had infection due 95% CI, 0.5 -3.6; P Å NS). For example, the management of to MRSA. Thirty-seven patients received vancomycin therapy 33 of the 37 patients for whom vancomycin was inappropriately inappropriately. There was no difference in outcome between used also failed to comply with a second recommendation the 68 patients who received and the 176 patients who did not (failure to undergo TEE, 14 patients; failure to remove an receive aminoglycoside therapy.
infected intravascular device, 16; failure to obtain blood for surveillance cultures, 1; and treatment for longer than recom-
Logistic Regression Analysis
mended, 2). The impact of several potential confounding variables was Logistic regression was performed to evaluate the impact of evaluated with logistic regression in a model containing comour recommendations on the outcome for patients. Each of the pliance with recommendations of infectious diseases specialists reasons why our recommendations were not followed (failure as the independent variable and death due to S. aureus infection to remove an intravascular device, failure to use b-lactam antior relapse as the outcome. Tested variables included infection biotics when possible, failure to perform TEE, failure to obtain with MRSA, diabetes mellitus, and hemodialysis dependence. blood for a surveillance culture, and antibiotic therapy for There was no significant difference in outcome when each of longer than recommended) (table 5) were considered for the these variables was controlled for separately in the model. model. The small numbers of patients for whom a surveillance blood culture was not performed or who received a prolonged Discussion course of antibiotics prevented analysis of these variables. Thus, the final model contained three variables (failure to reWe found that patients with S. aureus bacteremia whose physicians followed recommendations by infectious diseases move an intravascular device, failure to use b-lactam antibiot-consultants were significantly more likely to be cured and less Eighty percent of the patients in our study whose infected catheters or devices were not removed were hemodialysis-delikely to relapse than were similar patients with S. aureus bacteremia whose physicians ignored our recommendations. This pendent. This fact reflected treating physicians' attempts to preserve vascular access in patients with few alternate sites for lower rate of relapse occurred despite the fact that patients whose physicians followed our recommendations had signifilife-giving hemodialysis treatment. Unfortunately, such attempted salvage of vascular access resulted in relapse in over cantly more cases of metastatic infection and endocarditis at the onset of therapy than did patients whose physicians did one-half of the cases, and one of these patients died of recurrent staphylococcal sepsis. not follow our recommendations. This difference in outcome persisted even after multiple potential confounding variables Perform a surveillance blood culture. Because a surveillance blood culture was not performed for only two patients, were analyzed.
we were unable to assess the clinical value of this test. However, our findings were consistent with those of a previous
Study Strengths
investigation [19] that persistent bacteremia was associated with complicated staphylococcal infection. Thus, many cliniOur study design had several strengths. First, our recommencians may simply wish to treat all patients for whom surveildations were provided to each treating physician in the form lance blood cultures are positive for S. aureus with a long of a previously established algorithm. This design insured that course of intravenous antibiotics. uniform advice was provided to all treating physicians. Second, Use b-lactam therapy. Although our study was not dethe study was a large, prospective, and comprehensive investisigned to assess the comparative efficacy of vancomycin vs. gation. All patients were evaluated by one of the infectious b-lactam therapy, we recommended the use of b-lactam antibidiseases team, thereby maximizing the likelihood for an accuotics whenever possible because the use of vancomycin as an rate assessment of the patient. Third, a 12-week follow-up was antistaphylococcal agent has been associated with a high rate of performed for 99.6% of all our patients. Last, we used PFGE for clinical failure [10, 20 -22] . Since most patients who received most patients with recurrent bacteremia to address the potential vancomycin treatment because of reasons we deemed as inapconfounder of reinfection.
propriate were treated in other ways that were also in noncompliance with our management recommendations (e.g., failure to remove an intravascular device), we were unable to assess
Algorithm Recommendations
the clinical impact of vancomycin therapy on outcome. However, it is notable that all 18 patients with relapsed S. aureus Perform TEE. Several features of our algorithm warrant further discussion. First, our management schema recombacteremia that was confirmed by PFGE were treated with vancomycin. mended TEE 5 -7 days after diagnosis for all patients with S. aureus bacteremia. TEE was recommended because this modality is able to detect a significant number of cases of IE
Possible Confounding Features and Limitations
not identified by clinical examination or transthoracic echocardiography (TTE) [13 -17] . In a separate study [18] , we noted Our study has several limitations. First, this investigation did not randomize patients to groups with different management stratthat IE was present in 25 of 103 consecutive patients with S. aureus bacteremia who underwent both TTE and TEE. All egies. Although randomization of patients with S. aureus bacteremia to different treatment plans would be an ideal design, we 25 of these cases of IE were detected by TEE; however, only seven were detected by TTE. In light of this surprising finding, thought that denying an infectious diseases consultation to patients with serious staphylococcal infections was not possible. we reasoned that identification of patients with unsuspected endocarditis is critically important before application of a Because our study was not randomized, it is possible that physicians caring for hopelessly or terminally ill patients were treatment algorithm that includes an arm for short course therapy; thus, TEE was advised for all patients. As a result of this more likely to ignore our recommendations. Because our management recommendations involved prolonged therapy, invaapproach, we were able to identify 32 patients with endocarditis.
sive tests such as TEE, and the removal and replacement of intravascular devices, patients with a poorer prognosis might Remove infected intravascular devices. Our management algorithm included the recommendation that all infected intrahave been disproportionately represented among the group for whom these recommendations were not followed. However, vascular devices should be removed from patients with S. aureus bacteremia. Our data showed that failure to comply we doubt that this possibility had a significant impact on outcome since the rates of death and comorbid disease were similar with this recommendation was the most important risk factor for subsequent relapse or death due to S. aureus. Patients whose among the two groups.
The rates of colonization with S. aureus among diabetic [23] infected intravascular device was not removed were significantly more likely to relapse, thus suggesting that the removal and hemodialysis-dependent [24] patients are high, and the rate of S. aureus bacteremia among these patients may even be of such infected devices should be performed in most cases.
higher [25] . Because of these observations as well as the fact Third, the low mortality rate among our study patients may in part be related to the aggressive management of this potentially that hemodialysis dependence was more common among patients for whom our recommendations were not followed, these lethal disease. An infectious diseases team member saw all patients, and in each case, our management recommendations conditions were evaluated as potential confounders by using logistic regression analysis. In addition, the impact of infection were discussed with the treating team. Even among patients for whom our recommendations were not followed, the fact with MRSA was also evaluated by logistic regression analysis. No evidence was found that any of these conditions had a that an investigator evaluated the patient's case may have impacted upon the patient's care. For example, only 23 patients significant impact on the clinical outcome for our patients.
Acute and chronic illnesses in patients were also potential (9.4%) with an infected intravascular device did not have it removed and at least one set of surveillance blood cultures was confounders of our results [10, 26] . Our investigation did not assess acuity of illness by a standardized scoring system. Hownot performed for only two patients (1%). Furthermore, our recommendations were followed for most patients (93.8%) with ever, three factors suggest that disease acuity did not influence the cure and relapse rates. First, there was no significant differ-IE, an observation that has been made elsewhere [4] . ence in the mortality rates among the two study groups. Second, the rates of comorbidities among the two groups were similar. Last, patients whose physicians followed our recommendations Conclusions were often more acutely ill from their bacteremia than were patients whose physicians did not follow our recommendations.
Thus, patients whose physicians did not follow our recommendations were more likely to relapse than were patients For example, 30 (93.8%) of the 32 patients with IE were in the group for whom recommendations were followed. In addition, whose physicians did follow our recommendations. This finding persisted after consideration of host factors (acute severity other clinical indicators of acuity of illness (S. aureus pneumonia as the source of bacteremia, the presence of a rapidly fatal of illness, comorbid diseases, and site of infection), therapeutic factors (antibiotic regimen), and pathogen factors (infection disease, and the presence of CNS symptoms) that were found to be independent predictors of hospital mortality [27] were with MRSA and relapsed S. aureus bacteremia vs. reinfection).
To our knowledge, this is the first prospective study that atalso more common among patients whose physicians followed our recommendations than among those whose physicians did tempted to assess the importance of an infectious diseases consultation on the outcome for patients with S. aureus bacteremia. not follow our recommendations (17.0% vs. 14.9%, respectively).
Our finding that the rate of relapse was lower among patients with S. aureus bacteremia whose physicians followed the adFinally, the possibility of reinfection with a different strain of S. aureus represented another potential confounder. Howvice of infectious diseases consultants than among those whose physicians did not follow these recommendations has important ever, by means of PFGE analysis, 90% of the paired isolates from patients with recurrent S. aureus bacteremia were identiimplications. We believe that the benefit of our intervention was due to more than the formulation and dissemination of cal to isolates from the initial episode. This finding supports the explanation that most cases of recurrent S. aureus bactermanagement guidelines. These guidelines were intended to supplement but never replace clinical judgment and are likely emia were due to true relapsed infection.
to be modified as more data are gathered. Implementation of our management guidelines required individual assessment (as to the likely source of infection), interpretation of clinical and
Other Considerations laboratory findings (e.g., echocardiography), and judgment (e.g., concerning the significance of individual clinical findings The mortality rate associated with S. aureus bacteremia in our study was lower than that previously reported. Although in relation to the presence of metastatic disease). We believe that such a process is most likely to be successful when underearlier investigations found that the mortality rate among patients with S. aureus bacteremia ranged from 20% to 30%, we taken by infectious diseases specialists skilled in clinical medicine and knowledgeable about the myriad manifestations and found that the mortality rate attributable to S. aureus bacteremia was only 7.4%. There are several possible reasons for this complications of S. aureus bacteremia and its treatment. We hope that our study will prompt other investigators to finding. First, the median age of our study population was relatively young (57.5 years [interquartile range, 27 years]).
confirm these findings and undertake randomized trials of the efficacy and cost-effectiveness of intervention by infectious Most studies have shown that mortality rates among elderly patients with S. aureus bacteremia and IE are higher than those diseases specialists in cases of common infectious diseases. Furthermore, we hope that the results of these studies will among younger adult patients [28 -32] . Second, over one-half of our patients had catheter-associated bacteremia. Catheterprompt generalists and third-party payers to recognize the importance of infectious diseases consultation even in cases of associated S. aureus bacteremia usually is associated with a lower complication rate and better outcome when the catheter S. aureus bacteremia, where the diagnosis is obvious. Indeed, our findings suggest that successful treatment of S. aureus is promptly removed [33 -35] .
